Glytec Stock
Glytec is the pioneer of personalized digital therapeutics, enabling best practices for insulin management.
Sign up today and learn more about Glytec Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Glytec Stock
Funding History
| July 2009 | $131K |
|---|---|
| January 2011 | $100K |
| June 2011 | $2.0M |
| September 2011 | $8.3M |
| November 2012 | $4.0M |
| July 2013 | $3.5M |
| November 2013 | $3.0M |
Management
VP Quality Initiatives
Raymie McFarland
VP Client Development
Scott Rape
President and CEO
Bob Leonard
Chief Medical Officer
Andrew Rhinehart
VP Clinical Services
Melanie Mabrey
Chief Financial Officer
John Beneke
SVP Research & Development
Robby Booth
Press
drugdeliverybusiness - Jan, 26 2022
Glytec enters insulin management partnership with Nebraska Medicinebiospace - Jan, 13 2022
Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedsidedrugdeliverybusiness - Jan, 5 2022
Glytec garners cybersecurity certification for insulin management systemvator - Jul, 15 2021
John Downey, Chief Commercial Officer at Glytec, on VatorNews podcastdrugdeliverybusiness - Jul, 14 2021
Glytec appoints chief medical officerbusinesswire - May, 19 2021
Palmetto Health to Use Glytec’s eGlycemic Management System® for Diabetes Carebusinesswire - May, 19 2021
New Research Further Validates Benefits of Personalized Diabetes Therapy Management Across the Continuum of Carebusinesswire - May, 19 2021
Novant Health Partners with Glytec to Advance Leadership Position in Patient-Centered Diabetes Carebusinesswire - May, 19 2021
Grady Health System Improves Diabetes Care With Glytec’s eGlycemic Management Systembusinesswire - May, 19 2021
Glytec Grows its Patent Portfolio with Another Notice of Allowance for its Precision Diabetes Management Technologiesbusinesswire - May, 19 2021
Dramatic Readmission Reductions for CABG, CHF and AMI Attributed to Glytec’s eGlycemic Management Systembusinesswire - May, 19 2021
Study Conducted at Fred Hutch Shows Transplant Patients Benefit from Glytec’s System for Computer-Guided Glucose Managementbusinesswire - May, 19 2021
Glytec Named Fierce Innovation Awards Finalist, Healthcare Edition, for Precision Diabetes Management Solutionbusinesswire - May, 19 2021
Study Published by Journal of Diabetes Science and Technology Demonstrates Glytec’s Superiority in Meeting ADA Guidelinesbusinesswire - May, 19 2021
Glytec Receives Three Additional Patent Notices of Allowance from USPTO for its Breakthrough Diabetes Technologiesbusinesswire - May, 19 2021
Survey Reveals Better Care Needed for Hospitalized Patients with Diabetesbusinesswire - May, 19 2021
Glytec Introduces Quality Team to Assist Healthcare Organizations With Achieving Clinical Excellence in Diabetes Carebusinesswire - May, 19 2021
Northeast Georgia Medical Center to Implement eGlycemic Management System® from Glytecbusinesswire - May, 19 2021
Study Presented at American Diabetes Association 79th Scientific Sessions Observed Substantially Less Hypoglycemia With Use of Glytec’s Technologybusinesswire - May, 19 2021
Glytec Goes Global, With Six New International Patent Allowancesbusinesswire - May, 19 2021
Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert with CGM, Smart Pens and Other Diabetes Technologiesbusinesswire - May, 19 2021
Metro Health - University of Michigan Health to Use Glytec’s Software for Inpatient Diabetes Carebusinesswire - May, 19 2021
Glytec Receives Another Patent Allowance for Therapy Advisorbusinesswire - May, 19 2021
Computerized Systems for Managing Glucose Will Become Standard of Care in Hospitals, Anticipates Dr. Bruce Bodebusinesswire - May, 19 2021
Study by Riverside Medical Center Shows Reductions in Length of Stay and Hypoglycemia with Glytec's Insulin Optimization Solutionbusinesswire - May, 19 2021
Novant Health Goes Live With Glytec’s eGlycemic Management Systembusinesswire - May, 19 2021
Adventist Health System Deploys Glytec’s eGlycemic Management Systembusinesswire - May, 19 2021
Glytec publishes free eBook: Hypoglycemia in the hospital. Why is it costing you millions and what can you do?businesswire - May, 19 2021
Glytec Receives Two More Patent Allowances for its Insulin Optimization Systembusinesswire - May, 19 2021
Major Academic Health System Taps Glytec for Insulin Management Technologybusinesswire - May, 19 2021
Glytec Adds Smart Meter to Growing Network of Connected Solution Partnersbusinesswire - May, 19 2021
University of New Mexico Hospital to Bolster Patient Safety and Diabetes Care in Partnership with Glytecbusinesswire - May, 19 2021
Two More Patent Allowances for Glytec’s Diabetes Softwarebusinesswire - May, 19 2021
Glytec Announces Appointment of Ed Furlong as Chief Operating Officerbusinesswire - May, 19 2021
Piedmont Healthcare Expands Use of Glytec’s Software for Insulin Therapy Managementbusinesswire - May, 19 2021
Study Shows Computer-Guided Insulin Dosing Plus More Frequent Blood Glucose Testing Leads to Better Outcomes for Patients with Diabetesbusinesswire - May, 19 2021
Glytec’s Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technologybusinesswire - May, 19 2021
USPTO Grants Glytec Patent Allowance for Computer-Guided Selection and Dosing of All Diabetes Medicationsbusinesswire - May, 19 2021
Glytec Awarded Patent Allowance Supporting Connected Care Model for Insulin Managementbusinesswire - May, 19 2021
Chesapeake Regional Healthcare will Implement Glytec’s Software to Bolster High-Reliability Carebusinesswire - May, 19 2021
Glytec Integrates With Onduo Virtual Diabetes Clinicbusinesswire - May, 19 2021
Study Observed Improvements in Transitions of Care Using Hospital-to-Home Diabetes Therapy Management Software from Glytecbusinesswire - May, 19 2021
Adventist Health System Partners with Glytec to Enhance Diabetes Carebusinesswire - May, 19 2021
New Research Shows People on Insulin for Diabetes Maintain A1C Reductions Through Digital Therapy Managementbusinesswire - May, 19 2021
Glytec Announces Fourth FDA 510(k) Clearance for Its Market-Leading Diabetes Therapy Management Softwarebusinesswire - May, 19 2021
Presentation at AADE Conference Showcases Value of Diabetes Decision Support Solutionsbusinesswire - May, 19 2021
Glytec Receives Five Additional Patent Allowances for its Diabetes Therapy Management Softwarebusinesswire - May, 19 2021
Case Studies Presented at Diabetes Technology Society Conference Highlight Millions in Hospital Cost Savings with Improved Glucose Controlbusinesswire - May, 19 2021
Study Shows Computer-Guided Insulin Titration Enables Basal Bolus Standard of Carebusinesswire - May, 19 2021
Research Study from Emory University Observes $3,654 Per Patient Cost Savings for CABG Surgeryvator - Apr, 27 2021
Insulin management software provider Glytec raises $21Mnews - Apr, 26 2021
Exclusive: Glytec Raises $21M Round For In-hospital Glycemic Managementdrugdeliverybusiness - Mar, 31 2021
Glytec launches new insulin management systembusinesswire - Mar, 4 2020
Glytec and AdventHealth Highlight the Broad Impact of Electronic Glycemic Management at HIMSS 2020businesswire - May, 15 2019
Glytec and Onduo to Deliver Webinar on Virtual Diabetes Care in Partnership with HIMSSprnewswire - Mar, 29 2019
DarioHealth Partners With Glytec on Outpatient Diabetes Managementbusinesswire - Jan, 16 2019
At a Cost of $10,405 Per Patient Stay, Hypoglycemia in The Hospital Cannot Be Ignoredbusinesswire - Dec, 21 2018
Paula LeClair Joins Glytec as Executive Director and General Manager, OutpatientEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
